首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 46 毫秒
1.
对C4水平以下节段性颈椎后纵韧带骨化(OPLL)33例行前路骨化韧带切除术,29例随访1-10a,按JOA标准评定疗效。结果:优13例;良10例;改进3例,无变化2例;有效率89.6%,提示:C4以一段性OPLL适合前路开槽切除;C4以上的节段性OPLL或连续型OPLL适合后路椎板成形椎管扩大术。充分暴露骨化灶的范围,才能将其完整切除。  相似文献   

2.
对C_4水平以下节段性颈椎后纵韧带骨化(OPLL)33例行前路骨化韧带切除术。29例随访1~10a,按JOA标准评定疗效。结果:优(术后改善率80%以上)13例;良(50%~79%)10例;改进(5%~49%)3例;无变化(5%以下)2例;加重1例,有效率89.6%。提示:C_4以下节段性OPLL适合前路开槽切除;C_4以上的节段性OPLL或连续型OPLL适合后路椎板成形椎管扩大术。充分暴露骨化灶的范围,才能将其完整切除。  相似文献   

3.
颈椎后纵韧带骨化症及其外科治疗(附76例报告)   总被引:1,自引:0,他引:1  
目的:研究不同手术方式对颈椎后纵韧带骨化症(OPLL)的治疗效果和远期影响。方法本组76例患者均行手术治疗,其中颈前路减压+植骨融合术18例,颈后路半椎板减压43例,全椎板减压4例,椎管成形术11例(单开门5例,双开门5例)。结果:手术减压治疗效果的优良率为79.7%,但不同术式对远期效果的影响不同,部分患者出现后颈椎失稳,其中全椎板减压术的发生率为50%,半椎板减压术为22.2%,颈前路术压+植  相似文献   

4.
作者回顾分析16例颈椎后纵韧带骨化症(OPLL)的影像资料和手术治疗情况。颈椎X线侧位平片对本病的显示率为68.75%。核磁共振(MRI)能显示颈髓受压后的外形改变和髓内病变,但对OPLL不敏感,必须结合CT检查才能诊断。作者对连续型和混合型OPLL采用C3-7颈后路单开门扩大成形术或全椎板切除的方法,对局限型OPLL采取颈前路环锯减压+底部潜行扩大并刮除骨化韧带+自体植骨融合或前后路二次手术,疗效满意。  相似文献   

5.
目的:分析3种颈椎前路融合术的疗效。方法:用3种融合方式对160例脊髓型颈椎病(cervical spondylotic myelopathy,CSM)患者行前路减压。其中,单纯髂骨植骨(A组)双节段32例,3节段18例;植骨融合并颈椎前路钢板内固定(B组)双节段33例,3节段19例;钛网并前路钢板内固定(C组)双节段36例,3节段22例。术后定期随访及拍摄X线片,观察疗效、椎间高度、颈椎前弯曲度和融合情况。结果:平均随访时间2.2年,经过随访,A组融合率为83.1%,B组融合率为96.7%,C组融合率为96.4%。终访时,A组平均椎间高度和颈椎前弯曲度较术后早期显著性降低(P〈0.051,B组和C组则无显著性差异(P〉0.05)。A组与B和C组之间远期疗效均有显著性差异(P〈0.05),B组和C组之间远期疗效无显著性差异(P〉0.05)。结论:单纯髂骨植骨方法简单,但并发症较多。颈椎前路钢板植骨融合内固定和钛网并前路钢板内固定,固定牢固,符合颈椎生物力学特性,并发症少,远期疗效好。  相似文献   

6.
目的:比较颈椎后路手术及前路手术治疗多节段颈椎压迫(3个节段以上包括3个节段)的临床效果。方法:102例颈椎手术患者,随机分为前路手术组及后路手术组。统计2组患者术前后JOA评分、手术时间、术中出血量、术后轴性症状出现的比例,分析影像学改善(椎管椎体比值、脑脊液通畅)情况。结果:2组术后JOA评分均较术前提高,且后路组优于前路组( P〈0.01)。后路组手术时间少于前路组(P〈0.01)。2组出血量差异无统计学意义(P〉0.05)。后路组术后出现颈项部、肩背部肌肉酸痛、无力、僵硬、活动受限,查体有压痛点和肌肉痉挛者3例,前路组2例。后路组患者颈椎管与椎体的矢状径比值优于前路组(P〈0.01)。后路组术后颈椎MRI显示脑脊液通畅率明显优于前路组(P〈0.01)。结论:颈椎后路手术的临床效果优于前路手术。  相似文献   

7.
关于颈椎后纵韧带骨化症的流行病学调查分析   总被引:4,自引:0,他引:4  
作者通过对长春地区人群1029人做颈椎后纵韧带骨化症(OPLL)的流行病学调查分析,在国内首次提出OPLL患病率2.33%,其在各类颈椎疾患中占4.44%。另外提出性别、职业、临床症状、颈椎好发节段、并发症等项的调查结果。将OPLL的病因推论为一种特殊类型的退化性变化。  相似文献   

8.
作者通过对长春地区人群1029人做颈椎后纵韧带骨化症(OPLL)的流行病学调查分析,在国内首次提出OPLL患病率2.33%,其在各类颈椎疾患中占4.44%。另外提出性别、职业、临床症状、颈椎好发节段、并发症等项的调查结果。将OPLL的病因推论为一种特殊类型的退行性变化。  相似文献   

9.
目的比较颈椎前路减压后前路一体化钢板椎间融合器结构重建和自体髂骨结构重建两种手术方法稳定性、融合率和疗效。方法56例行颈前路减压融合术的病例,按手术方式分为2组,其中颈椎前路减压自体髂骨植骨融合术组(A组)19例,颈椎前路椎间盘切除减压前路一体化钢板椎间融合器融合术组(B组)37例。术前、术后不同时期进行JOA评分,以判定临床疗效,同时测量D值(颈椎整体曲度)、融合节段前高(heightofanteriorbody,HAB)、融合节段后高(heightofposteriorbody,HPB)以及Cobb角(颈椎活动度)。依据融合标准判定并计算术后各时期减压节段融合率。采用配对t检验比较两组间每-参数术后各时期值与术前值的差值。结果术后3个月,A、B组减压节段融合率分别为89.5%(17/19)、83.8%(31/37),术后6个月全部随访病例达到骨性融合。与A组比较,B组融合节段后高差值(术后1周-术前)差异无统计学意义,其他各时期差异有统计学意义;两组活动Cobb角差值(术后24个月-术前)差异有统计学意义,而此前各个时期活动Cobb角差值差异无统计学意义;两组术后不同时期JOA改善率、D值差值、融合节段前高差值的差异均无统计学意义。结论颈椎前路减压-体化钢板椎间融合器融合术取得良好的疗效,在维持融合节段后高及改善颈椎活动度方面更具优势。  相似文献   

10.
多节段颈椎病前路选择性手术的评价   总被引:29,自引:0,他引:29  
目的:分析不同颈前路手术对多工段颈椎病的治疗效果。方法:选择47例患手术后情况时间回顾,第1组7例为单一平面颈前路椎间盘切除植骨融合术患,第2组26例为多平面颈前路椎间盘切除植骨融合术患,第3组14例为颈椎次全椎体切除术患,采用日本矫形外科学会(JOA)评分标准评价术后随访结果。结果:第2,3组手术效果好于第I组,但并发症发生率也较第1组高,第2,3组间手术效果无显差别,第3组术后并发症  相似文献   

11.
FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…  相似文献   

12.
Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.  相似文献   

13.
In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.  相似文献   

14.
Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.  相似文献   

15.
16.
目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P<0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P<0.05),PaCO2均随观察时间的延长而降低(P<0.05).观察组治疗有效率为87.5%,显著高于对照组的70.0% (P <0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P<0.05),且观察组明显低于对照组(P<0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.  相似文献   

17.
CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.  相似文献   

18.
Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.  相似文献   

19.
OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.  相似文献   

20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号